BioSight
Latest round
- Series C
Last raised
- Dec 2020
Total raised
- $46M
Investors
- 7
About BioSight
BioSight Ltd.Founded in 2000 and headquartered in Lod, Israel, BioSight Ltd. is engaged in the development of cancer therapies.00 mn., Migdal Insurance Company, Phoenix Insurance Company, and Primera Capital.BioSight Ltd. specializes in developing innovative cancer therapeutics, focusing on enhancing treatment outcomes for patients with various malignancies. The company is known for its proprietary drug delivery platform, which optimizes the therapeutic index of chemotherapeutic agents. Its flagship product targets specific cancer types and aims to address unmet medical needs in oncology.BioSight generates revenue through strategic partnerships and collaborations within the pharmaceutical industry. Its revenue model is based on licensing agreements and milestone payments linked to the progression of its therapeutic products through clinical development.BioSight Ltd. The company is focusing on launching new products aimed at specific oncology markets and enhancing its proprietary drug delivery mechanisms. Plans for geographic expansion include targeting additional regions in Europe and North America, with specific timelines for new market entries yet to be disclosed.
Who invested in BioSight
7 investors across 2 rounds
See all investors in BioSight
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioSight
Who invested in BioSight?
BioSight has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioSight raised?
BioSight has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did BioSight last raise money?
BioSight's most recent round on record is a Series C, in Dec 2020.
What does BioSight do?
BioSight is a pharmaceuticals company.
Where is BioSight headquartered?
BioSight is headquartered in Lod, Israel.
Which VCs invest in companies like BioSight?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at BioSight's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like BioSight? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.